Project Grant R01AG087790
- Federal Grant Award Summary Georgetown University received a $788,121 Project Grant award from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), effective August 1, 2025, through April 30, 2030. This five-year multidisciplinary research initiative investigates Alzheimer's disease (AD) and related dementias (ADRD) risk factors in a historically underrepresented population: older Black/African Americans living with HIV. The study employs cross-sectional,...
- Federal Grant Award Summary Sri International received a $1.26M Project Grant from the National Institute on Aging (CFDA 93.866, Aging Research) effective September 15, 2025, through August 31, 2027. The award funds scientific research investigating the glymphatic system's role in cognitive decline among aging populations with human immunodeficiency virus (HIV) infection. The project will employ advanced magnetic resonance imaging (MRI) techniques to evaluate brain waste clearance mechanisms and...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded a K08 Career Development Award of $163,080 to The University of Texas Health Science Center at San Antonio, with an award date of September 9, 2025, and completion date of July 31, 2030, under the Aging Research program (CFDA 93.866). This project grant supports research to bridge critical knowledge gaps in plasma biomarker performance for Alzheimer's disease and related dementias (ADRDS) across diverse populations...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded Brain Research Africa Initiative a $215,995 Project Grant effective February 1, 2026, through January 31, 2028, under the Aging Research program (CFDA 93.866). The project will develop and validate a tablet-based, multi-domain digital cognitive assessment tool adapted specifically for use in Cameroon to address the critical gap in Alzheimer's disease and related dementias (ADRD) research and diagnosis in...
- Summary of Federal Project Grant Award The National Institute on Aging awarded $129,330 in Project Grant funding to Massachusetts General Hospital (The General Hospital Corporation) under the Aging Research program (CFDA 93.866) for the period June 15, 2025 through March 31, 2030. This award supports research addressing the critical challenge of early detection and accurate diagnosis of Alzheimer's Disease and Related Dementias (ADRD) through development of a machine learning-based prediction...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded Massachusetts General Hospital a $1.58 million Project Grant on March 15, 2025, under the Aging Research program (CFDA 93.866) to conduct research characterizing microvascular impairment in adults with elevated genetic risk for Alzheimer's disease. The research initiative, which extends through January 31, 2030, investigates the physiological mechanisms through which the apolipoprotein E-epsilon 4 (APOE-E4) allele—the...
- Federal Grant Award Summary The National Institute on Aging awarded a $684,567 Project Grant to Massachusetts General Hospital (The General Hospital Corporation) for a four-year research initiative beginning March 1, 2026 and concluding December 31, 2029, under the Aging Research program (CFDA 93.866). The grant supports a resubmission methodology study designed to assess the utility of 64Copper-Fibrin-Binding-Probe-8 Positron Emission Tomography (64Cu-FBP8 PET) for in vivo detection and...
- Summary The National Institute on Aging (NIA) awarded $447,626 in project grant funding (CFDA 93.866 - Aging Research) to the College of Medicine at the University of Ibadan on September 22, 2025, through August 31, 2027. This award supports a two-year cross-sectional and longitudinal research study investigating plasma biomarkers of cognitive decline and Alzheimer's Disease (AD) in Nigeria, with particular attention to the role of social determinants of health and lifestyle factors. The...
- Federal Grant Award Summary The National Institute on Aging awarded a $441,612 Project Grant to Boston University Medical Campus effective May 15, 2025, under the Aging Research program (CFDA 93.866) to investigate the relationship between modifiable lifestyle risk factors and digital cognitive markers in Alzheimer's disease progression. The research leverages the Framingham Heart Study's multi-generational cohort to develop and validate digital cognitive assessment methods—including digital pen...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded the University of Alabama at Birmingham $5,057,416 under the Aging Research program (CFDA 93.866) on September 15, 2025, for a four-year project period extending through September 14, 2029. This project grant addresses critical gaps in evidence supporting implementation of the Healthy Brain Initiative (HBI) Road Map by examining the impact of undiagnosed Alzheimer's disease and related dementias (ADRD) on...
The National Institute on Aging awarded a $738,105 Project Grant to Massachusetts General Hospital (awarded February 15, 2026, with completion by January 31, 2031) under the Aging Research program (CFDA 93.866) to conduct a comprehensive epidemiological and clinical research study examining cognitive impairment, Alzheimer's disease, and related dementias among people living with HIV in Uganda. The research deliverables include neuropsychological assessments of 600 older adults (both HIV-positive with virologic suppression and HIV-negative controls) conducted annually over four years, diagnostic classification of mild cognitive impairment and Alzheimer's disease and related dementias using multi-disciplinary case consensus criteria, and identification of pathophysiologic contributors through advanced plasma biomarkers and neuroimaging. The study leverages machine learning methodologies to elucidate underlying disease mechanisms and establish cognitive performance trajectories between the two populations. This project addresses a significant public health gap in sub-Saharan Africa, where over 25 million people living with HIV are reaching older age without established data on dementia risk in this population. By combining comprehensive neuropsychological testing, brain magnetic resonance imaging, fluid and imaging biomarkers, and machine learning analysis, the research aims to determine disease phenotypes and etiologies while examining social and clinical health determinants specific to the Ugandan context—factors that cannot be extrapolated from other populations and are essential for developing effective prevention and treatment strategies.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $738.1k | 2/3/26 |